Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: J Mol Cell Cardiol. 2009 Apr 1;47(2):228–237. doi: 10.1016/j.yjmcc.2009.03.018

Fig. 2.

Fig. 2

Effect of BSO treatment on myocardial contractility using the Langendorff perfused heart system (Panel A: LVDP; Panel B: + dP/dt; and Panel C: − dP/dt) in FVB and metallothionein (MT) transgenic mice treated with or without BSO. Mean ± SEM, n = 3 independent mice per group, * p < 0.05 vs. FVB group, # p < 0.05 vs. FVB-BSO group, $ p < 0.05 vs. MT group.